Combining Transarterial Chemoembolization with Sorafenib Improves Survival in Selected Patients with Hepatocellular Carcinoma and Extrahepatic Spread: A Multicenter Real-World Study.

J Hepatocell Carcinoma · 2025 · PMC12765703 · PMID 41496748

Europe PMC DOI

hedged sentence

0.1360

closest p · 2.7× alpha

0.1360

boldest claim

The sentences

did not reach statistical significancep = 0.136not close (p > 0.1)

Although the DCR was numerically higher with TACES (57.8% vs 48.9%), this difference did not reach statistical significance (OR = 1.43, 95% CI: 0.92–2.21; p = 0.136).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.